European Union - English - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - asthma - drugs for obstructive airway diseases, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

European Union - English - EMA (European Medicines Agency)

novartis europharm limited - indacaterol maleate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - hirobriz breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease.

European Union - English - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol maleate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - oslif breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease.

European Union - English - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol maleate - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - onbrez breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - indacaterol maleate 0.194mg;  ;  ;   - powder filled inhalation capsule - 150 mcg - active: indacaterol maleate 0.194mg       excipient: gelatin lactose monohydrate opacode black s-1-277002 - onbrez® breezhaler® is a long-acting beta2-agonist indicated for long-term, once-daily, maintenance bronchodilator treatment of airflow limitation in patients with chronic obstructive pulmonary disease.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - indacaterol maleate 0.389mg;  ;  ;   - powder filled inhalation capsule - 300 mcg - active: indacaterol maleate 0.389mg       excipient: gelatin lactose monohydrate opacode - onbrez® breezhaler® is a long-acting beta2-agonist indicated for long-term, once-daily, maintenance bronchodilator treatment of airflow limitation in patients with chronic obstructive pulmonary disease.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis pharma stein ag - indacaterol (indacaterol maleate), glycopyrronium (glycopyrronium bromide) - powder for inhalation, hard capsules - 110mcg+50mcg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - indacaterol acetate , glycopyrronium bromide , mometasone furoate - powder for inhalation in hard capsules - 150mcg/50mcg/80mcg

Kenya - English - Pharmacy and Poisons Board

nvs kenya limited p.o box 46057-00100 gpo nairobi - indacaterol maleate, glycopyrronium bromide - inhalation powder, hard capsule - 110/50mcg - alimentary tract and metabolism

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

siegfried barbera s.l. - indacaterol (indacaterol maleate), glycopyrronium bromide, mometasone fuora - powder for inhalation, capsules hard - 150mcg+ 50mcg+ 160mcg